Background: Vascular smooth muscle tone is regulated by changes in intracellular free Ca 2؉ concentration ([Ca 2؉ ] i ) and myofilament Ca 2؉ sensitivity. These cellular mechanisms could serve as targets for anesthetic agents that alter vasomotor tone. This study tested the hypothesis that propofol increases myofilament Ca 2؉ sensitivity in pulmonary artery smooth muscle (PASM) via the protein kinase C (PKC) signaling pathway.
VASCULAR smooth muscle tone is regulated by changes in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and myofilament Ca 2ϩ sensitivity. One consequence of increasing [Ca 2ϩ ] i is activation of Ca 2ϩ /calmodulin-depen-dent myosin light chain kinase (MLCK) and phosphorylation of the 20-kd myosin light chain (LC20), which results in an increase in cross-bridge cycling and tension development. Parallel to this process, other mechanisms can either modulate the regulation of myosin activity (thick filament-based regulation) or regulate pathways terminating on actin-binding proteins (thin filamentbased regulation), resulting in alterations in myofilament Ca 2ϩ sensitivity. Cellular mechanisms that regulate [Ca 2ϩ ] i and/or myofilament Ca 2ϩ sensitivity could serve as targets for anesthetic agents that alter vasomotor tone.
Propofol is a widely used intravenous anesthetic for cardiac and noncardiac surgical cases. Our laboratory is systematically investigating the effects of propofol on pulmonary vascular regulation. We have previously observed that propofol potentiates the pulmonary vasoconstrictor responses to both hypoxia 1 and ␣ adrenoreceptor activation 2 in dogs that were instrumented long-term. Propofol potentiated hypoxic pulmonary vasoconstriction by inhibiting K ϩ ATP -mediated pulmonary vasodilation. 1 Propofol potentiated ␣ adrenoreceptor-mediated pulmonary vasoconstriction by inhibiting the concomitant production of a vasodilator metabolite of the cyclooxygenase pathway. 3 In the present in vitro study, we tested the hypothesis that propofol may also have a direct effect on pulmonary vascular smooth muscle tone. Specifically, we tested the hypothesis that propofol increases myofilament Ca 2ϩ sensitivity in isolated canine pulmonary artery smooth muscle (PASM). Simultaneous measurement of [Ca 2ϩ ] i and tension allowed us to assess changes in PASM myofilament Ca 2ϩ sensitivity. We also tested the hypothesis that a propofol-induced increase in myofilament Ca 2ϩ sensitivity is mediated via the protein kinase C (PKC) signaling pathway.
Materials and Methods
All experimental procedures and protocols were approved by the Cleveland Clinic Foundation Institutional Animal Care and Use Committee (Cleveland, Ohio).
Preparation of Pulmonary Arterial Smooth Muscle Strips
Healthy male mongrel dogs weighing 24 -32 kg were anesthetized with pentobarbital sodium (30 mg/kg, intravenous) and fentanyl citrate (15 g/kg, intravenous). After tracheal intubation, the lungs were mechanically ventilated. A catheter was placed in the right femoral artery, and the dogs were killed by controlled hemorrhage. A left lateral thoracotomy was performed through the fifth intercostal space, and the heart was arrested with induced ventricular fibrillation. The heart and lungs were removed from the thorax en bloc, and the lower right and left lung lobes were dissected free. Intralobar pulmonary arteries (2-4 mm ID) were dissected carefully and immersed in cold modified Krebs-Ringer's bicarbonate (KRB) solution. The arteries were cleaned of connective tissue and cut into strips (2 ϫ 8 mm). The endothelium was removed by gently rubbing the intimal surface with a cotton swab. Endothelial denudation was later verified by the absence of a vasorelaxant response to acetylcholine (10 Ϫ6 M).
Simultaneous Measurement of Tension and Intracellular Ca 2ϩ Concentration
Pulmonary arterial strips without endothelium were loaded with 5 ϫ 10 Ϫ6 M acetoxylmethyl ester of fura-2 (fura-2/AM) solution, as described previously. 3 A noncytotoxic detergent, 0.05% Cremophor EL (Sigma Chemical, St. Louis, MO), was added to solubilize the fura-2/AM in the solution. After fura-2 loading, the arterial strips were washed with KRB buffer to remove uncleaved fura-2/AM and mounted between two stainless steel hooks in a temperature-controlled (37°C) 3-ml cuvette. The strips were continuously perfused at 12 ml/min with the KRB solution bubbled with 95% air and 5% CO 2 (pH 7.4). One hook was anchored and the other was connected to a strain gauge transducer (Grass FTO3, Grass Instrument Co., Quincy, MA) to measure isometric tension. The resting tension was adjusted to 4.0 g, which was determined in preliminary studies to be optimal for achieving a maximum contractile response to 30 mM KCl. Fluorescence measurements were performed using a dual-wavelength spectrofluorometer (Deltascan RFK6002, Photon Technology International, Lawrenceville, NJ) at excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm. Because calculations of absolute concentrations of [Ca 2ϩ ] i rely on a number of assumptions, the 340 to 380 fluorescence ratio (340/380 ratio) was used as a measure of [Ca 2ϩ ] i . The individual 340 and 380 signals were measured in all experiments, and the signals were observed to change in opposite directions in response to the various interventions. Because each PASM strip served as its own control, background fluorescence was assumed to be constant and was not subtracted from the calculated 340/380 ratio. The temperature of all solutions was maintained at 37°C in a water bath. Fura-2 fluorescence signals (340 and 380 nm and 340/380 ratio) and tension were measured at a sampling frequency of 2 Hz, and collected with a software package from Photon Technology International.
Experimental Protocols
We measured tension and [Ca 2ϩ ] i simultaneously to investigate how propofol alters the relation between tension and [Ca 2ϩ ] i in pulmonary artery smooth muscle. In protocol 1, time control experiments were performed to assess the reproducibility of KCl-induced increases in [Ca 2ϩ ] i and tension. The PASM strips (n ϭ 6) were treated with 30 mM KCl. After changes in [Ca 2ϩ ] i and tension had reached new steady state values (10 -15 min), the strips were washed with fresh KRB solution and [Ca 2ϩ ] i and tension returned to baseline. After a return to baseline, a period of 10 -15 min was allowed before the second application of 30 mM KCl. This same procedure was followed for the third application of 30 mM KCl.
In protocol 2, we tested the hypothesis that the Ca 2ϩ channel antagonist, verapamil, and the intravenous anesthetic propofol would have differential effects on KClinduced changes in [Ca 2ϩ ] i and tension. Once again the experimental design was similar to protocol 1. After the first application of KCl, the PASM strips (n ϭ 6, each) were pretreated with either propofol (10 M) or verapamil (0.1 M) for 10 min. This was followed by the second application of 30 mM KCl. The strips were then washed with fresh KRB buffer. After a return to baseline values, the strips were pretreated with either propofol (100 M) or verapamil (0.3 M) for 10 min. This was followed by the third application of 30 mM KCl. In additional PASM strips (n ϭ 5), a similar procedure was followed to assess the effects of higher concentrations of verapamil (1 and 10 M) on KCl-induced increases in [Ca 2ϩ ] i and tension.
In protocol 3, we investigated the effects of propofol on the [Ca 2ϩ ] i -tension relation by increasing the extracellular Ca 2ϩ concentration. In each PASM strip (n ϭ 5), the response to 30 mM KCl was assessed first. After washout, the strips were treated with a Ca 2ϩ -free buffer containing 2 mM EGTA for 10 min. This solution was replaced with a Ca 2ϩ -free solution that did not contain EGTA. After 10 min, this solution was replaced with a Ca 2ϩ -free solution containing 30 mM KCl. Finally, after 10 min, the extracellular Ca 2ϩ concentration was increased in control and propofol-pretreated (100 M) strips in an incremental fashion from 0 mM to 0.25, 0.5, 1, and 3 mM. In protocols 1-3, changes in tension and [Ca 2ϩ ] i are expressed as a percentage of the response to the first application of 30 mM KCl.
In protocol 4, we eliminated the possible inhibitory effect of propofol on increases in [Ca 2ϩ ] i in response to KCl-induced depolarization, 4 which could mask a propofol-induced increase in myofilament Ca 2ϩ sensitivity. To do this, we performed experiments where [Ca 2ϩ ] i was increased using the Ca 2ϩ ionophore ionomycin (0.1 M). First, increases in tension and [Ca 2ϩ ] i in response to 60 mM KCl were obtained. We used 60 mM KCl as our reference response in this protocol because in prelimi-nary experiments we observed that ionomycin increased [Ca 2ϩ ] i to approximately 50% of the value induced by 60 mM KCl. The strips were then washed with fresh KRB solution. After tension and [Ca 2ϩ ] i had returned to baseline, ionomycin (0.1 M) was administered. This concentration of ionomycin had essentially no effect on tension, whereas it increased [Ca 2ϩ ] i to approximately 50% of the value induced by 60 mM KCl. In this setting, propofol (1, 10, 100 M) was administered cumulatively to the perfusion solution. The same procedure was repeated in strips pretreated with bisindolylmaleimide I (BIS, 1 M), a specific PKC inhibitor, 5 or Gö 6976 (10 M), a selective inhibitor of Ca 2ϩ -dependent PKC isoforms. 6 We also investigated the effects of phorbol 12-myristate 13-acetate (PMA, 1 M), a specific PKC activator, on tension and [Ca 2ϩ ] i in ionomycin-treated strips in the presence and absence of BIS. To determine whether an increase in [Ca 2ϩ ] i is required for propofol-induced changes in tension, propofol (1, 10, 100 M) was administered to PASM strips (n ϭ 3) in the absence of extracellular Ca 2ϩ (Ca 2ϩfree solution containing 2 mM EGTA) and after pretreatment with the IP 3 -receptor antagonist 2-aminoethoxydiphenyl borate (2-APB, 100 M, Calbiochem, La Jolla, CA), to inhibit propofol-induced changes in Ca 2ϩ release from the sarcoplasmic reticulum. 4 In protocol 4, changes in tension and [Ca 2ϩ ] i are expressed as a percentage of the response to 60 mM KCl.
Solutions and Chemicals
The KRB solution had the following composition: 118.3 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 2.5 mM CaCl 2 , 25 mM NaHCO 3 , 0.016 mM Ca-EDTA, and 11.1 mM glucose, gassed with 95% air and 5% CO 2 at 37°C, pH 7.4. The KCl solutions were prepared in an isotonic fashion by replacing NaCl with equimolar KCl. The following chemicals were used: fura-2/AM (Texas Fluorescence Labs, Austin, TX), acetylcholine chloride, ionomycin, BIS, PMA, Cremophor EL, Gö 6976, and 2-APB. The BIS, Gö 6976, and ionomycin were dissolved in dimethyl sulfoxide and diluted with distilled water. The final concentration of dimethyl sulfoxide in the organ bath was less than 0.1% (vol/vol). In control experiments, none of the agents or solutions used in this study caused significant shifts in the fluorescence signals in fura-2 nonloaded PASM strips, suggesting that changes in fluorescence of endogenous substances are negligible.
Data Analysis
All values are expressed as mean Ϯ SEM. Statistical analysis used analysis of variance, Student paired t test, and the Bonferroni test for multiple comparisons. The peak tension-[Ca 2ϩ ] i relations were compared using linear regression analysis. A P value of less than 0.05 was considered statistically significant. In all experiments, n equals the number of dogs from which the PASM strips were obtained. For each protocol, multiple strips from the same dog were averaged, so that all dogs were weighted equally in the analysis. Figure 1 illustrates changes in tension and the 340, 380, and 340/380 fura-2 fluorescence signals in a PASM strip in response to three sequential applications of 30 mM KCl. Increases in [Ca 2ϩ ] i and tension in response to the second and third application of 30 mM KCl are summarized as a percentage of the first KCl response. Changes in tension (108 Ϯ 5 and 99 Ϯ 4%) and [Ca 2ϩ ] i (96 Ϯ 2 and 90 Ϯ 3%) in response to sequential treatments of 30 mM KCl were highly reproducible. Figure 2 illustrates the effects of verapamil and propofol on original recordings of changes in [Ca 2ϩ ] i and tension induced by 30 mM KCl. The KCl caused a monotonic increase in tension that was maintained at a peak value as well as a monotonic increase in [Ca 2ϩ ] i that slightly decreased from a peak value. Inhibition of L-type Ca 2ϩ channels with verapamil (0.1 and 0. with verapamil (0.64 Ϯ 0.08 vs. 1.07 Ϯ 0.08, respectively, P Ͻ 0.05). When higher concentrations of verapamil (1 and 10 M) were used to further reduce KClinduced increases in tension and [Ca 2ϩ ] i , the slope of the peak tension-[Ca 2ϩ ] i relation (1.17 Ϯ 0.10) was similar to that observed with the lower concentrations of verapamil and significantly higher (P Ͻ 0.05) than that observed with propofol. Moreover, PKC inhibition with BIS completely reversed the propofol-induced decrease in the slope of the peak tension-[Ca 2ϩ ] i relation in response to KCl depolarization (BIS plus propofol, 100 M, slope ϭ 1.26 Ϯ 0.10). These results suggest that propofol increases myofilament Ca 2ϩ sensitivity in PASM via a PKCsensitive pathway.
Results

Effects of Sequential Application of KCl on KCl-induced Increases in [Ca 2ϩ ] i and Tension
Effects of Verapamil and Propofol on KCl-induced Increases in [Ca 2ϩ ] i and Tension
Effects of Propofol on [Ca 2ϩ ] i -tension Relation when Extracellular Ca2ϩ Is Increased
To more directly assess the effects of propofol on myofilament Ca 2ϩ sensitivity, control and propofol-pretreated PASM strips bathed in a Ca 2ϩ -free buffer containing 30 mM KCl were exposed to incremental increases in extracellular Ca 2ϩ concentration. As summarized in figure 4, increasing extracellular Ca 2ϩ concentration resulted in virtually identical increases in [Ca 2ϩ ] i in control and propofol-pretreated strips, whereas concomitant increases in tension were greater (*P Ͻ 0.05) in propofolpretreated strips compared with control. This resulted in a shift in the [Ca 2ϩ ] i -tension relation, such that for a given value of [Ca 2ϩ ] i , tension was greater in the propofol-pretreated strips compared with the control. Figure 5 illustrates original recordings of changes in [Ca 2ϩ ] i and tension induced by propofol in the presence or absence of the specific PKC inhibitor, BIS. To eliminate the inhibitory effect of propofol on increases in [Ca 2ϩ ] i in response to KCl-induced depolarization, which could mask a propofol-induced increase in myofilament Ca 2ϩ sensitivity, the PASM strips were pretreated with the Ca 2ϩ ionophore, ionomycin (0.1 M), to increase [Ca 2ϩ ] i . Ionomycin had essentially no effect on tension, whereas it increased [Ca 2ϩ ] i to approximately 50% of the value induced by 60 mM KCl ( fig. 5 ). During these conditions, propofol caused a dose-dependent increase in tension but had little effect on [Ca 2ϩ ] i . Pretreatment with BIS before ionomycin administration attenuated the increases in tension in response to propofol. Summarized data are shown in figure 6 . Propofol significantly increased tension, whereas [Ca 2ϩ ] i was slightly decreased. Pretreatment with BIS attenuated the propofol-induced changes in tension and [Ca 2ϩ ] i . Figure 7 summarizes the effects of the PKC activator PMA on [Ca 2ϩ ] i and tension in ionomycin-pretreated strips in the presence and absence of BIS. As observed with propofol, PMA increased tension, whereas [Ca 2ϩ ] i was slightly decreased. Pretreatment with BIS abolished the PMA-induced changes in tension and [Ca 2ϩ ] i . These results indicate that increases in myofilament Ca 2ϩ sensitivity in response to PMA involve the PKC signaling pathway.
Effects of Protein Kinase C Inhibition on Propofol-induced Increases in [Ca 2ϩ ] i and Tension in Ionomycin-pretreated Strips
Effects of Protein Kinase C Inhibition on PMA-induced Increases in [Ca 2ϩ ] i and Tension in Ionomycin-pretreated Strips
Effects of Inhibition of Ca 2ϩ -dependent Protein Kinase C Isoforms on Propofol-induced Increases in [Ca 2ϩ ] i and Tension in Ionomycin-pretreated Strips
As summarized in figure 8 , pretreatment with Gö 6976, a selective inhibitor of Ca 2ϩ -dependent PKC isoforms, also attenuated the propofol-induced increase in tension and the decrease in [Ca 2ϩ ] i in ionomycin-pretreated strips, though this effect was only apparent at the highest concentration of propofol. To determine whether an increase in [Ca 2ϩ ] i is required for the propofol-induced increase in tension, propofol (1, 10, and 100 M) was administered to the PASM strips in the absence of extracellular Ca 2ϩ and after pretreatment with the IP 3 receptor antagonist 2-APB to inhibit Ca 2ϩ release from the sarcoplasmic reticulum. During these conditions, propofol had no effect on tension or [Ca 2ϩ ] i .
Discussion
This is the first study to assess the effects of propofol on myofilament Ca 2ϩ sensitivity in PASM. Our results demonstrate that propofol increases myofilament Ca 2ϩ sensitivity. Moreover, this effect is attenuated by a specific inhibitor of PKC and an inhibitor of Ca 2ϩ -dependent PKC isoforms. These results suggest that the propofol-induced increase in myofilament Ca 2ϩ sensitivity involves the PKC signaling pathway.
The results from protocol 1 demonstrated that triplicate responses to KCl cause reproducible and consistent increases in [Ca 2ϩ ] i and tension. Our next goal was to determine whether propofol alters the relation between KCl-induced changes in tension and [Ca 2ϩ ] i in PASM. The KCl-induced increases in tension are mediated by Ca 2ϩ influx through L-type, voltage-gated Ca 2ϩ channels, which results in an increase in [Ca 2ϩ ] i , phosphorylation of myosin light chain, and tension development. Thus, the L-type Ca 2ϩ channel blocker verapamil would be expected to inhibit KCl-induced increases in tension and [Ca 2ϩ ] i to a similar extent, as was reported previously in isolated guinea pig aortae. 7 This assumes that verapamil has no effect on myofilament Ca 2ϩ sensitivity, which was reported in canine coronary arteries. 8 In contrast to verapamil, propofol attenuated KCl-induced increases in [Ca 2ϩ ] i to a greater extent than concomitant increases in tension. This was reflected by an upward shift in the peak tension-[Ca 2ϩ ] i relation, suggesting an increase in myofilament Ca 2ϩ sensitivity. It is important to note that this method to assess the effects of propofol on myofilament Ca 2ϩ sensitivity has limitations (e.g., unknown effects of propofol on neurotransmitter release) and does not alone provide direct proof that propofol increases myofilament Ca 2ϩ sensitivity. To more directly assess this possibility, we investigated the effects of propofol in PASM strips perfused with a Ca 2ϩ -free solution containing 30 mM KCl (protocol 3). During these conditions, increasing extracellular Ca 2ϩ concentration in an incremental fashion caused virtually identical increases in [Ca 2ϩ ] i in control and propofol-pretreated strips, whereas concomitant increases in tension were greater in propofol-pretreated strips. Thus, for a given value of [Ca 2ϩ ] i , tension was greater during propofol compared with control; that is, propofol increased myofilament Ca 2ϩ sensitivity. Taken together, our results suggest that propofol has at least two opposing effects on KCl-induced contraction. Propofol has been shown to inhibit L-type, voltage-gated Ca 2ϩ channels in systemic vascular smooth muscle, 4,9 tracheal smooth muscle cells, 10 and myocardial cells. 11 Thus, it is likely that the inhibitory effect of propofol on KCl-induced increases in tension and [Ca 2ϩ ] i in PASM is due to inhibition of L-type, voltage-gated Ca 2ϩ channels. However, this ef-fect is partially offset by a concomitant propofol-induced increase in PASM myofilament Ca 2ϩ sensitivity.
The effects of propofol on myofilament Ca 2ϩ sensitivity may depend on the species and/or the tissue type being investigated. Propofol had no effect on myofilament Ca 2ϩ sensitivity in the absence or presence of muscarinic receptor stimulation in ␤-escin-permeabilized canine tracheal smooth muscle, even at supraclinical concentrations. 12 Propofol was reported to decrease myofilament Ca 2ϩ sensitivity in rat ventricular myocytes at supraclinical concentrations. 13 In contrast, Nakae et al. 14 < 0.05 vs. control) . Results are expressed as percentage changes relative to response to 60 mM KCl. n ‫؍‬ 6, each. lated guinea pig hearts. Our laboratory 15 has reported that propofol increases myofilament Ca 2ϩ sensitivity in rat cardiomyocytes. Recently, we 16 demonstrated in cardiomyocytes that propofol increases the sensitivity of myofibrillar actomyosin adenosine triphosphatase to Ca 2ϩ (i.e., increases myofilament Ca 2ϩ sensitivity), at least in part by increasing intracellular pH via a PKCdependent activation of Na ϩ -H ϩ exchange. In the present study, propofol caused an upward shift in the PASM peak tension-[Ca 2ϩ ] i relation compared with verapamil-induced changes and a shift in the [Ca 2ϩ ] i -tension relation when extracellular Ca 2ϩ concentration was increased incrementally from a Ca 2ϩ -free condition. Moreover, in ionomycin-pretreated PASM strips, propofol caused a dose-dependent increase in tension without a concomitant increase in [Ca 2ϩ ] i . These results clearly indicate that propofol increases myofilament Ca 2ϩ sensitivity in PASM.
reported that clinically relevant concentrations of propofol increased myofilament Ca 2ϩ sensitivity in iso-
Fig. 5. Original tracings demonstrating the effects of the specific protein kinase C (PKC) inhibitor bisindolylmaleimide I (BIS) on propofol-induced changes in tension and [Ca 2؉ ] i (340/380 ratio) in ionomycin-pretreated pulmonary artery smooth muscle (PASM) strips. Propofol increased tension in a dose-dependent manner without a concomitant increase in [Ca 2؉ ] i . Pretreatment with BIS before ionomycin administration attenuated the propofol-induced changes in tension and [Ca 2؉ ] i .
Fig. 6. Summarized data for the effects of bisindolylmaleimide I (BIS) on propofolinduced changes in tension and [Ca 2؉ ] i (340/380 ratio) in ionomycin-pretreated pulmonary artery smooth muscle (PASM) strips. Propofol increased tension in a dose-dependent manner with a slight concomitant decrease in [Ca 2؉ ] i (*P < 0.05 vs. baseline). Pretreatment with BIS attenuated the propofol-induced increases in tension and decreases in [Ca 2؉ ] i ( †P
Based on our previous results in cardiomyocytes, 16 we next tested the hypothesis that propofol increases PASM myofilament Ca 2ϩ sensitivity via activation of the PKC signaling pathway. In the ionomycin-pretreated PASM strips, the propofol-induced increases in tension and decreases in [Ca 2ϩ ] i were attenuated by BIS, a specific inhibitor of PKC. Moreover, the PKC activator PMA mimicked the effects of propofol in the ionomycin-pretreated PASM strips; that is, PMA also increased tension and decreased [Ca 2ϩ ] i . These PMA-induced changes were abolished by BIS. Taken together, these results suggest that the propofol-induced increase in myofilament Ca 2ϩ sensitivity and the concomitant decrease in [Ca 2ϩ ] i involve PKC activation.
The primary mechanisms of contraction in vascular smooth muscle involve Ca 2ϩ /calmodulin-dependent, ML-CK-dependent phosphorylation of LC20, 17, 18 and myofilament Ca 2ϩ sensitization. 19 The PKC has been implicated in the signaling pathway that regulates myofilament Ca 2ϩ sensitivity. 20 Some reports 21,22 indicate that PKC-mediated contraction is Ca 2ϩ dependent, [23] [24] [25] whereas other studies suggest that it is Ca 2ϩ independent. We recently identified six isoforms of PKC in canine PASM cells, 26 representing the classic, novel, and atypical PKC isoform groups. Two of the isoforms (PKC␣ and PKC␦) underwent translocation in response to the PKC activator dioctanoylglycerol and in response to angiotensin II. PKC␣ is a member of the classic group A PKC isoforms, which are Ca 2ϩ dependent. PKC␤ and PKC␥ are also members of the classic group A PKC isoforms but are not present in PASM. 26 PKC␦ is a member of the novel group B PKC isoforms, which are Ca 2ϩ independent. In the present study, selective inhibition of Ca 2ϩ -dependent PKC isoforms with Gö 6976 attenuated the propofol-induced increases in tension and decreases in [Ca 2ϩ ] i . Also, Gö 6976 was shown to inhibit the vasoconstrictor responses to angiotensin II 27 and hypoxia 28 in intact lungs. Moreover, our observation that propofol had no effect on tension during experimental conditions that prevented an increase in [Ca 2ϩ ] i (i.e., absence of extracellular Ca 2ϩ and after IP 3 -receptor block) underscores the Ca 2ϩ dependence of the propofol-induced, PKC-mediated increase in tension. Taken together, our results suggest that the propofol-induced increase in tension and decrease in [Ca 2ϩ ] i involves activation of PKC␣.
The cellular mechanisms by which propofol causes PKC-dependent changes in [Ca 2ϩ ] i and tension have yet to be identified. The effect of propofol on [Ca 2ϩ ] i could be due to either a PKC-mediated decrease in Ca 2ϩ influx (e.g., via L-type, voltage-gated Ca 2ϩ channels) or an increase in Ca 2ϩ extrusion. PKC is known to activate Na ϩ -Ca 2ϩ exchange 29 and/or Ca 2ϩ pumps. 30 Recently, we 31 demonstrated that propofol inhibits capacitative Ca 2ϩ entry in PASM cells via a PKC-dependent pathway. It is possible that the small decreases in [Ca 2ϩ ] i in response to propofol and PMA may be due to inhibition of capacitative Ca 2ϩ entry via the PKC signaling pathway. PKC has been postulated to increase myofilament Ca 2ϩ sensitivity via several mechanisms, including phosphorylation of thin-filament accessory proteins (e.g., caldesmon, calponin), inhibition of myosin light chain phosphatase, phosphorylation of myosin light chain, and activation of Na ϩ -H ϩ exchange, resulting in intracellular alkalinization. 19, 32 In contrast, PKC was not found to play an important role in norepinephrine-induced increases in myofilament Ca 2ϩ sensitivity in PASM. 33 A possible limitation of that study is that [Ca 2ϩ ] i and tension were not measured simultaneously in the same tissue. 33 Moreover, the study by Janssen et al. 33 used endothelium-intact pulmonary arterial rings that were not pretreated to inhibit the ␤-agonist effect of norepinephrine. These factors could confound interpretation of norepinephrine-induced changes in tension. Finally, it should be noted that neither BIS nor Gö 6976 abolished the propofol-induced increases in PASM tension. This suggests that other signaling mechanisms that regulate myofilament Ca 2ϩ sensitivity (e.g., tyrosine kinases, Rhokinase) could be involved.
Ionomycin is a Ca 2ϩ ionophore that increases [Ca 2ϩ ] i , both via an increase in sarcolemmal Ca 2ϩ influx and via Ca 2ϩ release from intracellular stores. This latter effect could in turn lead to activation of capacitative Ca 2ϩ entry. As previously reported, 34 we observed that ionomycin induced a smaller contraction than that predicted from the concomitant increase in [Ca 2ϩ ] i . The precise mechanism underlying this ionomycin-induced dissociation between tension and [Ca 2ϩ ] i is unknown. One possible mechanism is that, because ionomycin can inhibit mitochondrial activity, 35, 36 decreased adenosine triphosphate production may dissociate contraction from increases in [Ca 2ϩ ] i . Alternatively, ionomycin itself may decrease myofilament Ca 2ϩ sensitivity. This possibility needs to be considered when interpreting the effects of propofol in the ionomycin-pretreated PASM strips.
The plasma concentration of propofol in patients during maintenance of general anesthesia was reported to be in the range of 10 Ϫ5 to 10 Ϫ4 M. 37 Because 97-98% of propofol is bound to plasma proteins, 38 the free concentration of propofol is approximately 10 Ϫ6 to 10 Ϫ5 M. However, protein binding of propofol in vivo is unlikely to be instantaneous, so the free drug concentration associated with a bolus injection would be higher than the steady state value. Moreover, it was demonstrated recently that 28% of propofol is taken up by the lung during a single passage through the lung, and most of the propofol that undergoes pulmonary uptake is released back into the circulation by back diffusion. 39 This results in a higher concentration of propofol in the pulmonary artery than in the radial artery. 40 In this study, propofol concentrations of 10 Ϫ5 M and higher significantly increased tension without increasing [Ca 2ϩ ] i in ionomycintreated pulmonary arterial strips. This result indicates that propofol can increase PASM myofilament Ca 2ϩ sensitivity at clinically relevant concentrations.
In conclusion, propofol has a direct inhibitory effect on PASM contraction that is mediated by a decrease in the availability of [Ca 2ϩ ] i . Propofol also increases PASM myofilament Ca 2ϩ sensitivity, and this effect is at least partially mediated by the PKC signaling pathway. Indirect evidence suggests an involvement of PKC␣. Future studies will be required to determine whether propofol also increases myofilament Ca 2ϩ sensitivity during receptor activation.
